Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- PAGE-1_AG1Independent statistical analysis of Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01426516).
- PAHIndependent statistical analysis of Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03638908).
- PAI vs FNBIndependent statistical analysis of Analgesia After Total Knee Arthroplasty: Peri-Articular Injection Versus Epidural + Femoral Nerve Blockade: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pain and Sensory Changes Assessment in HIV+ Patients: Complete Statistical AnalysisIndependent statistical analysis of Pain and Sensory Changes Assessment in HIV+ Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00422695).
- Pain Control Following Sinus Surgery: Complete Statistical AnalysisIndependent statistical analysis of Pain Control Following Sinus Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03783702).
- Pain Control for Intrauterine Device Placement: A Trial of Ketorolac Prior to Intrauterine Device Placement: Complete Statistical AnalysisIndependent statistical analysis of Pain Control for Intrauterine Device Placement: A Trial of Ketorolac Prior to Intrauterine Device Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pain Expectations in Subjects With Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Pain Expectations in Subjects With Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02155257).
- Pain in Traumatic Brain Injury – Basile, MD: Complete Statistical AnalysisIndependent statistical analysis of Pain in Traumatic Brain Injury - Basile, MD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01136486).
- Pain Informed Movement for People With Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Pain Informed Movement for People With Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05730829).
- Pain Management in Teeth With Reversible Pulpitis: Complete Statistical AnalysisIndependent statistical analysis of Pain Management in Teeth With Reversible Pulpitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07114198).
- Pain Outcomes Following Intralesional Corticosteroid Injections: Complete Statistical AnalysisIndependent statistical analysis of Pain Outcomes Following Intralesional Corticosteroid Injections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03630198).
- Pain Perception With Tenaculum Placement: Complete Statistical AnalysisIndependent statistical analysis of Pain Perception With Tenaculum Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02969421).
- Pain Relief Satisfaction With New Educational Materials: Complete Statistical AnalysisIndependent statistical analysis of Pain Relief Satisfaction With New Educational Materials: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03698773).
- Pain Study of Rectus Muscle Closure at Cesarean Delivery: Complete Statistical AnalysisIndependent statistical analysis of Pain Study of Rectus Muscle Closure at Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00505362).
- Pain, Inflammation and Opioid Craving: Complete Statistical AnalysisIndependent statistical analysis of Pain, Inflammation and Opioid Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04190563).
- Pain, Psychiatric Disorders, and Disability Among Veterans With and Without Polytrauma: Complete Statistical AnalysisIndependent statistical analysis of Pain, Psychiatric Disorders, and Disability Among Veterans With and Without Polytrauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Painted Playgrounds: Aim 2: Assessments: Complete Statistical AnalysisIndependent statistical analysis of Painted Playgrounds: Aim 2: Assessments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03885518).
- Paired Promotion of Colorectal Cancer and Social Determinants of Health Screening: Complete Statistical AnalysisIndependent statistical analysis of Paired Promotion of Colorectal Cancer and Social Determinants of Health Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PAIRSIndependent statistical analysis of Study of Aripiprazole to Treat Children and Adolescents With Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00619190).
- PAL-HFIndependent statistical analysis of Palliative Care in Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01589601).
- PALACEIndependent statistical analysis of Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PALACE-1Independent statistical analysis of Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PALACE4Independent statistical analysis of Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food: Complete Statistical AnalysisIndependent statistical analysis of Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3): Complete Statistical AnalysisIndependent statistical analysis of Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children: Complete Statistical AnalysisIndependent statistical analysis of Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PALLASIndependent statistical analysis of PALbociclib CoLlaborative Adjuvant Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02513394).
- Palliative Care Consultations in the Skilled Nursing Facility (SNF) Setting: Complete Statistical AnalysisIndependent statistical analysis of Palliative Care Consultations in the Skilled Nursing Facility (SNF) Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03958552).
- Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer: Complete Statistical AnalysisIndependent statistical analysis of Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients: Complete Statistical AnalysisIndependent statistical analysis of Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PALSIndependent statistical analysis of Physical Activity and Leisure-time Study (PALS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01342471).
- Palu-COVIDIndependent statistical analysis of Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Pamidronate to Treat Osteogenesis Imperfecta in Children: Complete Statistical AnalysisIndependent statistical analysis of Pamidronate to Treat Osteogenesis Imperfecta in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00005901).
- PAMMIndependent statistical analysis of Physiological Augmentation of Mindfulness Meditation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02754557).
- PAMSIndependent statistical analysis of Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PANAMAIndependent statistical analysis of PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PANCAX-3Independent statistical analysis of Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pancreas Resection With and Without Drains: Complete Statistical AnalysisIndependent statistical analysis of Pancreas Resection With and Without Drains: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01441492).
- Pancreaticobiliary Reflux in Patients Without Cholelithiasis: Complete Statistical AnalysisIndependent statistical analysis of Pancreaticobiliary Reflux in Patients Without Cholelithiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00890201).
- PanECTIndependent statistical analysis of Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention: Complete Statistical AnalysisIndependent statistical analysis of Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02588339).
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01105312).
- Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size…
- PANORAMA_3Independent statistical analysis of Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02654990).
- PANTHEONIndependent statistical analysis of A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction: primary endpoint results, effect estimate with confidence interval, sample-size…
- PANTHERIndependent statistical analysis of Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD): primary endpoint results, effect estimate…